Patients interested in GHK-Cu peptide therapy often seek support for: Results vary by patient and treatment protocol
Diabetes costs in the U.S
Your body is going to be a little bit more protective of itself because we all need to have some level of fat on our bodies." This flared-up reaction towards hunger and calorie retention is the body's self-protection instincts kicking in
Medications and devices referenced include: SGLT2 Inhibitors Farxiga, Jardiance, Invokana, Steglatro, dapagliflozin GLP-1 Receptor Agonists / GIPs Mounjaro, Ozempic, Rybelsus, Trulicity, Victoza, liraglutide Anti-Obesity Medications Contrave, Lomaira, phentermine, Qsymia, Saxenda, Wegovy, Zepbound Continuous Glucose Monitors (CGMs) Device brands preferred by each payor Plans include major commercial plans/PBMs in Michigan (Aetna, BCBSM, Express Scripts, HAP, Priority Traditional, Priority Optimized, and United), as well as Medicare, Medicare Advantage plans (Aetna, BCBSM/BCN, HAP, Humana, Priority, United, and Wellcare), and Michigan Medicaid
This investigational drug is designed to combat obesity and is particularly noteworthy for its potential once-monthly dosing, which could offer a significant advantage over existing treatments that typically require more frequent administration
J.MolloyK.CryanS